Search

everythinglearnresearchcommunity

for

Search:↓

A woman's masculine symptoms were caused by a rare tumor in her left ovary, which was found using a special blood test.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

Skin problems like excessive hair growth, acne, and dark skin patches can be signs of Polycystic Ovarian Disease, which may also be linked to family history and a risk for diabetes.

A postmenopausal woman's virilization was caused by a rare ovarian tumor that was hard to detect but was successfully treated with surgery.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Indian women with PCOS from Delhi and Srinagar show different symptoms, with Delhi women having higher obesity and blood sugar issues, and Srinagar women showing more hair growth and testosterone levels.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

The document concludes that accurate diagnosis of hair disorders is crucial and requires a range of diagnostic methods.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.